Understanding Migraine Without Aura: A Systemic Neurological Disease
At a Glance
Migraine without aura is a neurological condition that can cause severe, disabling attacks even without visual or sensory warning signs. Diagnosis is based on symptoms and history, and care may combine regular routines, migraine medicines, neuromodulation, and behavioral therapy.
If you have been diagnosed with migraine without aura, you may have heard it described as a “simple” migraine or even just a “bad headache.” However, medical research shows that this condition is a complex neurological disorder that can produce whole-body symptoms [1]. While it lacks the visual or sensory “warning signs” (aura) that some people experience, migraine without aura is actually the most common form of the disease and can be just as severe and disabling as any other type [2][3].
More Than Just Head Pain
Migraine without aura is not just a headache; it is a state of “brain sensitivity” that involves a distributed network of nerves and brain structures [4]. It is now understood as a disorder with effects across several body systems, contributing to the way your brain processes sensory information and interacting with your gut and immune function [1][5].
- Prevalence: Migraine without aura is the predominant phenotype, affecting approximately 10% of the global population [2]. In some studies, it is up to six times more common than migraine with aura, especially in women [6].
- Severity: Research comparing the two types finds that they share almost identical levels of pain intensity and associated symptoms like nausea [3]. The absence of an aura does not mean your condition is “milder” or requires less intensive treatment [7].
- The “Migraine Cycle”: An attack often starts long before the pain begins. This early phase, called the prodrome, can involve yawning, fatigue, or food cravings [8]. The nature of the disease means you may also experience symptoms like brain fog or digestive issues even after the head pain has faded [9].
The Biology of an Attack
The pain and sensitivity you feel are driven by specific biological pathways. Understanding these explanatory models can help you and your doctor choose the right treatments (and realize that you did not cause your own disease).
The Trigeminovascular System
The “highway” for migraine pain is the trigeminovascular system. This is a network that connects the trigeminal nerve (the main sensory nerve for your face and head) to the blood vessels in the protective lining of your brain [10]. During an attack, these nerves become “hypersensitized,” meaning they begin to fire pain signals even when there is no external injury [11].
CGRP: The Pain Messenger
A protein called CGRP (calcitonin gene-related peptide) plays a starring role in this process. CGRP is released from the nerve endings, triggering further nociceptive and sensory signaling [10].
- Researchers found that infusing CGRP into people with migraine can trigger an attack, supporting its causal role in the disease, though it is one pathway in a complex process [12].
- Newer “migraine-specific” treatments, such as gepants and monoclonal antibodies, work by specifically blocking CGRP or its receptor to stop this cycle [13][14].
The Migraine Network
While the pain happens in the nerves, the process involves a distributed network, including the brainstem and hypothalamus. These areas of the brain regulate basic functions like sleep, hunger, and your reaction to light and sound [4].
- Sensitization: When these centers are overactive, you may experience allodynia—a state where normal touch (like a shower or brushing your hair) feels painful [5].
- Environmental Sensitivity: The brain’s inability to “filter out” irrelevant sights or sounds explains why many people with migraine need to retreat to a dark, quiet room [5].
Managing a Neurological Condition
Because migraine involves several body systems, management often requires more than just a pill for the pain. Evidence-based strategies focus on stabilizing the nervous system.
- Routine as Medicine: The migraine brain thrives on consistency. Maintaining regular sleep patterns and meal times can help reduce the frequency of attacks by preventing the “dips” in energy that trigger the hypothalamus [15][16].
- Hydration and Movement: Staying hydrated is particularly important if you take certain medications like topiramate [17]. Regular physical activity has also been shown to lower the risk of attacks becoming more frequent over time [18].
- Beyond Medication: For some, non-drug options like neuromodulation (devices that use electrical pulses to calm the nerves) or behavioral therapies like Biofeedback can provide significant relief by teaching the body to manage its stress response [19][20].
Understanding Your Diagnosis
Doctors use the ICHD-3 (International Classification of Headache Disorders) to diagnose migraine without aura. This is a clinical diagnosis based on your history, not a blood test or an MRI [21]. To meet the criteria, attacks typically:
- Last between 4 and 72 hours (when untreated or unsuccessfully treated) [21].
- Have at least two pain characteristics: throbbing, moderate-to-severe intensity, on one side of the head, or worsened by movement [21].
- Include either nausea/vomiting or sensitivity to both light and sound [21].
If your symptoms don’t perfectly “fit” these boxes—for example, if your attacks are shorter or the pain is on both sides—you may still have migraine. Your doctor will use their clinical judgment to ensure you receive the correct care [21][22].
Common questions in this guide
Can migraine without aura be as severe as migraine with aura?
How is migraine without aura diagnosed?
What can happen before or after a migraine without aura attack?
Why can migraine without aura make light, sound, or touch feel painful?
What treatments and daily habits can help prevent migraine without aura attacks?
Does not having an aura change how migraine is treated?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my history of attacks, do I strictly meet the ICHD-3 criteria for migraine without aura?
- 2.Since migraine is a neurological disorder with whole-body symptoms, should we be monitoring or managing other health factors like my sleep, mood, or digestion alongside my head pain?
- 3.Given that my migraine attacks do not have an aura, does that change which acute or preventive medications you recommend for me?
- 4.What is my current level of migraine-related disability, and at what point would we consider adding a preventive treatment?
- 5.How can I distinguish between a 'prodrome' symptom and a lifestyle trigger, and should I be tracking these separately?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (22)
- 1
Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles.
Hautakangas H, Winsvold BS, Ruotsalainen SE, et al.
Nature genetics 2022; (54(2)):152-160 doi:10.1038/s41588-021-00990-0.
PMID: 35115687 - 2
Migraine with and without aura-two distinct entities? A narrative review.
Grodzka O, Dzagoevi K, Rees T, et al.
The journal of headache and pain 2025; (26(1)):77 doi:10.1186/s10194-025-01998-1.
PMID: 40229683 - 3
Evaluating migraine with typical aura with neuroimaging.
Karsan N, Silva E, Goadsby PJ
Frontiers in human neuroscience 2023; (17()):1112790 doi:10.3389/fnhum.2023.1112790.
PMID: 37025972 - 4
Hypothalamic structural integrity and temporal complexity of cortical information processing at rest in migraine without aura patients between attacks.
Porcaro C, Di Renzo A, Tinelli E, et al.
Scientific reports 2021; (11(1)):18701 doi:10.1038/s41598-021-98213-3.
PMID: 34548562 - 5
Deficient inhibition of irrelevant visual information in migraine: A magnetoencephalography study of alpha-band activity.
Masson R, ElShafei A, Demarquay G, et al.
Headache 2026; (66(7)):1459-1473 doi:10.1111/head.70108.
PMID: 42290392 - 6
Sex differences in clinical characteristics of migraine and its burden: a population-based study.
Chalmer MA, Kogelman LJA, Callesen I, et al.
European journal of neurology 2023; (30(6)):1774-1784 doi:10.1111/ene.15778.
PMID: 36905094 - 7
Migraine with aura.
Lucas C
Revue neurologique 2021; (177(7)):779-784 doi:10.1016/j.neurol.2021.07.010.
PMID: 34384631 - 8
Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine.
Guo S, Vollesen ALH, Olesen J, Ashina M
Pain 2016; (157(12)):2773-2781 doi:10.1097/j.pain.0000000000000702.
PMID: 27842045 - 9
Preserved working memory performance along with subcortical modulation during peri-ictal phases in spontaneous migraine attacks.
Ruiz-Tagle A, Caetano G, Fouto A, et al.
Headache 2025; (65(3)):407-419 doi:10.1111/head.14850.
PMID: 39397349 - 10
CGRP and the Trigeminal System in Migraine.
Iyengar S, Johnson KW, Ossipov MH, Aurora SK
Headache 2019; (59(5)):659-681 doi:10.1111/head.13529.
PMID: 30982963 - 11
Blink Reflex in Episodic and Chronic Migraine.
Polat B, Aysal F, Öztürk M, et al.
Noro psikiyatri arsivi 2018; (55(2)):146-151 doi:10.5152/npa.2017.12753.
PMID: 30057456 - 12
Calcitonin gene-related peptide induced migraine attacks in patients with and without familial aggregation of migraine.
Guo S, Christensen AF, Liu ML, et al.
Cephalalgia : an international journal of headache 2017; (37(2)):114-124 doi:10.1177/0333102416639512.
PMID: 26994300 - 13
Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention.
Schoenen J, Manise M, Nonis R, et al.
Revue neurologique 2020; (176(10)):788-803 doi:10.1016/j.neurol.2020.04.027.
PMID: 32758365 - 14
Characteristics associated with response to subcutaneously administered anti-CGRP monoclonal antibody medications in a real-world community cohort of persons living with migraine: A retrospective clinical and genetic study.
Chase BA, Semenov I, Rubin S, et al.
Headache 2024; (64(1)):68-92 doi:10.1111/head.14655.
PMID: 38071464 - 15
Current Perspectives on the Impact of Chronic Migraine on Sleep Quality: A Literature Review.
Saçmacı H, Tanik N, İnan LE
Nature and science of sleep 2022; (14()):1783-1800 doi:10.2147/NSS.S335949.
PMID: 36225323 - 16
Was it something I ate? Understanding the bidirectional interaction of migraine and appetite neural circuits.
Martins-Oliveira M, Tavares I, Goadsby PJ
Brain research 2021; (1770()):147629 doi:10.1016/j.brainres.2021.147629.
PMID: 34428465 - 17
Topiramate in Migraine Prevention: A 2016 Perspective.
Silberstein SD
Headache 2017; (57(1)):165-178 doi:10.1111/head.12997.
PMID: 27902848 - 18
Environmental and psychological risk factors for migraine chronification in China: A multicenter prospective cohort study.
Ma L, Liu L, Ran Y, et al.
Cephalalgia : an international journal of headache 2026; (46(5)):3331024261446614 doi:10.1177/03331024261446614.
PMID: 42084558 - 19
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice.
Headache 2019; (59(1)):1-18 doi:10.1111/head.13456.
PMID: 30536394 - 20
Treatment Update of Chronic Migraine.
Cho SJ, Song TJ, Chu MK
Current pain and headache reports 2017; (21(6)):26 doi:10.1007/s11916-017-0628-6.
PMID: 28424953 - 21
Grey zones in the diagnosis of adult migraine without aura based on the International Classification of Headache Disorders-III beta: exploring the covariates of possible migraine without aura.
Ozge A, Aydinlar E, Tasdelen B
Pain research & management 2015; (20(1)):e1-7.
PMID: 25493966 - 22
Reconsideration of the diagnosis and treatment of childhood migraine: A practical review of clinical experiences.
Saito Y, Yamanaka G, Shimomura H, et al.
Brain & development 2017; (39(5)):386-394 doi:10.1016/j.braindev.2016.11.011.
PMID: 27993427
This page explains migraine without aura, its diagnosis, and management for informational purposes only and does not constitute medical advice. Discuss your symptoms and treatment options with your healthcare professional.
Get notified when new evidence is published on migraine without aura.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.